0001735276-19-000031.txt : 20190301
0001735276-19-000031.hdr.sgml : 20190301
20190301180940
ACCESSION NUMBER: 0001735276-19-000031
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190228
FILED AS OF DATE: 20190301
DATE AS OF CHANGE: 20190301
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KEATING LAURIE
CENTRAL INDEX KEY: 0001620743
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36407
FILM NUMBER: 19651046
MAIL ADDRESS:
STREET 1: 300 THIRD STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ALNYLAM PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001178670
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 770602661
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 300 THIRD STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: (617) 551-8200
MAIL ADDRESS:
STREET 1: 300 THIRD STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: ALNYLAM PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20020724
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2019-02-28
0
0001178670
ALNYLAM PHARMACEUTICALS, INC.
ALNY
0001620743
KEATING LAURIE
300 THIRD STREET
CAMBRIDGE
MA
02142
0
1
0
0
SVP, GC & Secretary
Stock Option (right to buy)
85.0
2019-02-28
4
A
0
25000
0.0
A
2029-02-27
Common Stock
25000
25000
D
Represents the time-vested portion of the reporting person's Annual Stock Option Award for 2018. The reporting person also received 12,500 performance stock units that will vest upon the achievement of three specific performance conditions, which will be reported on a Form 4 if and when each performance condition is met and the option vests.
The stock option vests as to 25% of the shares on the 1st anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter.
By: /s/ Mary Beth DeLena, Attorney-in-Fact For: Laurie Keating
2019-03-01